Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Synmosa Biopharma Corp (4114) Stock Price & Analysis

4114 Stock Chart & Stats

NT$27.20-NT$0.55(-1.98%)
At close: 12:30 AM EST
TWD 27.5TWD 30Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
TWD 26.40 - TWD 27.40
52-Week Range
TWD 26.40 - TWD 31.49
Previous Close
TWD 27.75
Volume
N/A
Average Volume (3M)
863.96K
Market Cap
TWD 14.62B
Enterprise Value
TWD 18.79B
Total Cash (Recent Filing)
TWD 2.78B
Total Debt (Recent Filing)
TWD 3.36B
Price to Earnings (P/E)
17.7
Beta
0.31
Next Earnings
Nov 18, 2026 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Jul 17, 2026
Dividend Yield
3.12%

4114 FAQ

What was Synmosa Biopharma Corp’s price range in the past 12 months?
Synmosa Biopharma Corp lowest stock price was TWD 26.40 and its highest was TWD 31.49 in the past 12 months.
What is Synmosa Biopharma Corp’s market cap?
Synmosa Biopharma Corp’s market cap is TWD 14.62B.
When is Synmosa Biopharma Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Synmosa Biopharma Corp’s earnings last quarter?
Synmosa Biopharma Corp released its earnings results on Aug 13, 2026. The company reported TWD 0.408 earnings per share for the quarter, beating the consensus estimate of TWD 0.407 by TWD 0.001.
Is Synmosa Biopharma Corp overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Synmosa Biopharma Corp pay dividends?
Synmosa Biopharma Corp pays a ― dividend of TWD 0.848 which represents an annual dividend yield of 3.12%. See more information on Synmosa Biopharma Corp dividends here
What is Synmosa Biopharma Corp’s EPS estimate?
Synmosa Biopharma Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Synmosa Biopharma Corp have?
Synmosa Biopharma Corp has 550,886,660 shares outstanding.
What happened to Synmosa Biopharma Corp’s price movement after its last earnings report?
Synmosa Biopharma Corp reported an EPS of TWD 0.408 in its last earnings report, beating expectations of TWD 0.407. Following the earnings report the stock price went up 0.671%.
Which hedge fund is a major shareholder of Synmosa Biopharma Corp?
Currently, no hedge funds are holding shares in TW:4114
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology